Femasys (FEMY) Competitors $0.37 -0.03 (-6.48%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$0.37 +0.00 (+0.63%) As of 04:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FEMY vs. SLNO, PSTV, MDAI, MLSS, GUTS, ZYXI, WOK, NEPH, NMTC, and MODDShould you be buying Femasys stock or one of its competitors? The main competitors of Femasys include Soleno Therapeutics (SLNO), Plus Therapeutics (PSTV), Spectral AI (MDAI), Milestone Scientific (MLSS), Fractyl Health (GUTS), Zynex (ZYXI), WORK Medical Technology Group (WOK), Nephros (NEPH), NeuroOne Medical Technologies (NMTC), and Modular Medical (MODD). These companies are all part of the "medical equipment" industry. Femasys vs. Its Competitors Soleno Therapeutics Plus Therapeutics Spectral AI Milestone Scientific Fractyl Health Zynex WORK Medical Technology Group Nephros NeuroOne Medical Technologies Modular Medical Femasys (NASDAQ:FEMY) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations. Do insiders and institutionals believe in FEMY or SLNO? 65.3% of Femasys shares are owned by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are owned by institutional investors. 11.5% of Femasys shares are owned by insiders. Comparatively, 6.4% of Soleno Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, FEMY or SLNO? Femasys has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFemasys$1.63M7.33-$18.82M-$0.86-0.43Soleno TherapeuticsN/AN/A-$175.85M-$4.14-12.36 Which has more risk and volatility, FEMY or SLNO? Femasys has a beta of -2.63, indicating that its share price is 363% less volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.71, indicating that its share price is 371% less volatile than the S&P 500. Do analysts prefer FEMY or SLNO? Femasys presently has a consensus target price of $7.33, indicating a potential upside of 1,899.82%. Soleno Therapeutics has a consensus target price of $115.09, indicating a potential upside of 124.92%. Given Femasys' higher possible upside, analysts plainly believe Femasys is more favorable than Soleno Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Femasys 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08 Is FEMY or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to Femasys' net margin of -1,113.72%. Soleno Therapeutics' return on equity of -73.74% beat Femasys' return on equity.Company Net Margins Return on Equity Return on Assets Femasys-1,113.72% -713.74% -152.60% Soleno Therapeutics N/A -73.74%-56.67% Does the media refer more to FEMY or SLNO? In the previous week, Soleno Therapeutics had 30 more articles in the media than Femasys. MarketBeat recorded 36 mentions for Soleno Therapeutics and 6 mentions for Femasys. Femasys' average media sentiment score of 0.74 beat Soleno Therapeutics' score of 0.59 indicating that Femasys is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Femasys 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 7 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Positive SummaryFemasys and Soleno Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FEMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FEMY vs. The Competition Export to ExcelMetricFemasysMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.77M$3.15B$5.80B$10.17BDividend YieldN/A2.32%5.72%4.61%P/E Ratio-0.4321.2475.0526.39Price / Sales7.33466.71544.00190.24Price / CashN/A44.4425.8129.91Price / Book3.679.6413.436.28Net Income-$18.82M-$53.20M$3.29B$270.38M7 Day Performance-1.95%0.07%0.08%1.89%1 Month Performance-48.36%4.27%4.61%6.01%1 Year Performance-67.26%9.62%75.02%25.26% Femasys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FEMYFemasys3.0775 of 5 stars$0.37-6.5%$7.33+1,899.8%-67.3%$12.77M$1.63M-0.4330Gap UpSLNOSoleno Therapeutics4.4348 of 5 stars$72.30+3.6%$115.09+59.2%-3.2%$3.71BN/A-17.4630Positive NewsShort Interest ↑PSTVPlus Therapeutics3.2258 of 5 stars$0.48-2.8%$7.88+1,548.2%-72.1%$48.78M$5.82M-0.2120Short Interest ↑Gap UpMDAISpectral AI2.9247 of 5 stars$1.87+2.7%$3.50+87.2%+54.3%$48.65M$29.58M-2.7183MLSSMilestone Scientific2.7085 of 5 stars$0.61-1.8%$1.25+106.2%-38.9%$48.48M$9.08M-8.6630Positive NewsShort Interest ↓GUTSFractyl Health2.8912 of 5 stars$0.93+0.7%$6.53+602.9%-64.8%$46.41M$90K-0.45102News CoveragePositive NewsAnalyst ForecastGap UpZYXIZynex2.3354 of 5 stars$1.46-2.0%$4.90+235.6%-81.8%$45.14M$192.35M-1.55770WOKWORK Medical Technology GroupN/A$0.78+0.3%N/A-82.8%$44.46M$11.51M0.00226Positive NewsNEPHNephros3.2335 of 5 stars$3.93+2.6%$5.50+39.9%+134.1%$40.60M$14.16M32.7530Short Interest ↓NMTCNeuroOne Medical Technologies2.6592 of 5 stars$0.85+7.2%$1.45+70.6%+6.0%$39.64M$3.45M-5.6720High Trading VolumeMODDModular Medical1.2488 of 5 stars$0.72+0.5%N/A-67.9%$39.59MN/A-1.4120News CoverageGap Up Related Companies and Tools Related Companies Soleno Therapeutics Alternatives Plus Therapeutics Alternatives Spectral AI Alternatives Milestone Scientific Alternatives Fractyl Health Alternatives Zynex Alternatives WORK Medical Technology Group Alternatives Nephros Alternatives NeuroOne Medical Technologies Alternatives Modular Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FEMY) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FEMY Stock Alerts